Bristol Myers Squibb & Johnson & Johnson Halt Phas...
Category : Clinical Trial Update 17 November 2025Bristol Myers Squibb (BMS) and Johnson & Johnson have jointly decided to stop the Phase 3 Librex...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
EMA Recommends Approval of Teizeild (Teplizumab) t...
Category : Clinical Trial Update 17 November 2025The European Medicines Agency (EMA) has recommended granting EU-wide marketing authorisation for Tei...
Akeso Receives NMPA Approval to Begin Clinical Tri...
Category : Clinical Trial Update 17 November 2025Akeso has reached a major scientific milestone. The company announced NMPA approval to begin clinica...
Fresenius Kabi Issues Voluntary U.S. Recall of Thr...
Category : Clinical Trial Update 14 November 2025Fresenius Kabi, a global healthcare company specializing in infusion, transfusion, and clinical nutr...
DBV Technologies Completes Last Patient Visit in P...
Category : Clinical Trial Update 14 November 2025DBV Technologies, a clinical-stage biopharmaceutical company focused on treatments for food allergie...
Latest Newsletter Post
-
Akeso Receives NMPA Approval to Beg..
17 November 2025
-
EMA Recommends Approval of Teizeild..
17 November 2025
-
Bristol Myers Squibb & Johnson & Jo..
17 November 2025
-
Phase 3 Trial of Investigational He..
14 November 2025
-
DBV Technologies Completes Last Pat..
14 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com